These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18190596)

  • 1. Mucolipidosis II: a single causal mutation in the N-acetylglucosamine-1-phosphotransferase gene (GNPTAB) in a French Canadian founder population.
    Plante M; Claveau S; Lepage P; Lavoie EM; Brunet S; Roquis D; Morin C; Vézina H; Laprise C
    Clin Genet; 2008 Mar; 73(3):236-44. PubMed ID: 18190596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene.
    Kudo M; Brem MS; Canfield WM
    Am J Hum Genet; 2006 Mar; 78(3):451-63. PubMed ID: 16465621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of 30 novel pathogenic variations in 69 unrelated Indian patients with Mucolipidosis Type II and Type III.
    Pasumarthi D; Gupta N; Sheth J; Jain SJMN; Rungsung I; Kabra M; Ranganath P; Aggarwal S; Phadke SR; Girisha KM; Shukla A; Datar C; Verma IC; Puri RD; Bhavsar R; Mistry M; Sankar VH; Gowrishankar K; Agrawal D; Nair M; Danda S; Soni JP; Dalal A
    J Hum Genet; 2020 Nov; 65(11):971-984. PubMed ID: 32651481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucolipidosis II and III alpha/beta in Brazil: analysis of the GNPTAB gene.
    Cury GK; Matte U; Artigalás O; Alegra T; Velho RV; Sperb F; Burin MG; Ribeiro EM; Lourenço CM; Kim CA; Valadares ER; Galera MF; Acosta AX; Schwartz IV
    Gene; 2013 Jul; 524(1):59-64. PubMed ID: 23566849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three novel homozygous mutations in the GNPTG gene that cause mucolipidosis type III gamma.
    Liu S; Zhang W; Shi H; Meng Y; Qiu Z
    Gene; 2014 Feb; 535(2):294-8. PubMed ID: 24316125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin and spread of a common deletion causing mucolipidosis type II: insights from patterns of haplotypic diversity.
    Coutinho MF; Encarnação M; Gomes R; da Silva Santos L; Martins S; Sirois-Gagnon D; Bargal R; Filocamo M; Raas-Rothschild A; Tappino B; Laprise C; Cury GK; Schwartz IV; Artigalás O; Prata MJ; Alves S
    Clin Genet; 2011 Sep; 80(3):273-80. PubMed ID: 20880125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of predominant GNPTAB gene mutations in Eastern Chinese patients with mucolipidosis II/III and a prenatal diagnosis of mucolipidosis II.
    Wang Y; Ye J; Qiu WJ; Han LS; Gao XL; Liang LL; Gu XF; Zhang HW
    Acta Pharmacol Sin; 2019 Feb; 40(2):279-287. PubMed ID: 29872134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lysosomal storage disorders mucolipidosis type II, type III alpha/beta, and type III gamma: Update on GNPTAB and GNPTG mutations.
    Velho RV; Harms FL; Danyukova T; Ludwig NF; Friez MJ; Cathey SS; Filocamo M; Tappino B; Güneş N; Tüysüz B; Tylee KL; Brammeier KL; Heptinstall L; Oussoren E; van der Ploeg AT; Petersen C; Alves S; Saavedra GD; Schwartz IV; Muschol N; Kutsche K; Pohl S
    Hum Mutat; 2019 Jul; 40(7):842-864. PubMed ID: 30882951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations.
    Encarnação M; Lacerda L; Costa R; Prata MJ; Coutinho MF; Ribeiro H; Lopes L; Pineda M; Ignatius J; Galvez H; Mustonen A; Vieira P; Lima MR; Alves S
    Clin Genet; 2009 Jul; 76(1):76-84. PubMed ID: 19659762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology.
    Paton L; Bitoun E; Kenyon J; Priestman DA; Oliver PL; Edwards B; Platt FM; Davies KE
    J Biol Chem; 2014 Sep; 289(39):26709-26721. PubMed ID: 25107912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portrait of autosomal recessive diseases in the French-Canadian founder population of Saguenay-Lac-Saint-Jean.
    Cruz Marino T; Leblanc J; Pratte A; Tardif J; Thomas MJ; Fortin CA; Girard L; Bouchard L
    Am J Med Genet A; 2023 May; 191(5):1145-1163. PubMed ID: 36786328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of mucolipidosis II/III GNPTAB missense mutations identifies domains of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase involved in catalytic function and lysosomal enzyme recognition.
    Qian Y; van Meel E; Flanagan-Steet H; Yox A; Steet R; Kornfeld S
    J Biol Chem; 2015 Jan; 290(5):3045-56. PubMed ID: 25505245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GNPTAB missense mutations cause loss of GlcNAc-1-phosphotransferase activity in mucolipidosis type II through distinct mechanisms.
    Ludwig NF; Velho RV; Sperb-Ludwig F; Acosta AX; Ribeiro EM; Kim CA; Gandelman Horovitz DD; Boy R; Rodovalho-Doriqui MJ; Lourenço CM; Santos ES; Braulke T; Pohl S; Schwartz IVD
    Int J Biochem Cell Biol; 2017 Nov; 92():90-94. PubMed ID: 28918368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-causing missense mutations within the N-terminal transmembrane domain of GlcNAc-1-phosphotransferase impair endoplasmic reticulum translocation or Golgi retention.
    Lee WS; Jennings BC; Doray B; Kornfeld S
    Hum Mutat; 2020 Jul; 41(7):1321-1328. PubMed ID: 32220096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucolipidosis II and III alpha/beta: mutation analysis of 40 Japanese patients showed genotype-phenotype correlation.
    Otomo T; Muramatsu T; Yorifuji T; Okuyama T; Nakabayashi H; Fukao T; Ohura T; Yoshino M; Tanaka A; Okamoto N; Inui K; Ozono K; Sakai N
    J Hum Genet; 2009 Mar; 54(3):145-51. PubMed ID: 19197337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two novel variants in GNPTAB underlying mucolipidosis II in a Pakistani family.
    Khan MA; Zubaida B; Karim N; Cheema HA; Naeem M
    J Pediatr Endocrinol Metab; 2020 May; 33(5):647-651. PubMed ID: 32238606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel splice site mutation in the GNPTAB gene in an Iranian patient with mucolipidosis II α/β.
    Hashemi-Gorji F; Ghafouri-Fard S; Salehpour S; Yassaee VR; Miryounesi M
    J Pediatr Endocrinol Metab; 2016 Aug; 29(8):991-3. PubMed ID: 27180337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel intermediate mucolipidosis II/IIIαβ caused by GNPTAB mutation in the cytosolic N-terminal domain.
    Leroy JG; Sillence D; Wood T; Barnes J; Lebel RR; Friez MJ; Stevenson RE; Steet R; Cathey SS
    Eur J Hum Genet; 2014 May; 22(5):594-601. PubMed ID: 24045841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AAV8-mediated expression of N-acetylglucosamine-1-phosphate transferase attenuates bone loss in a mouse model of mucolipidosis II.
    Ko AR; Jin DK; Cho SY; Park SW; Przybylska M; Yew NS; Cheng SH; Kim JS; Kwak MJ; Kim SJ; Sohn YB
    Mol Genet Metab; 2016 Apr; 117(4):447-55. PubMed ID: 26857995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilated cardiomyopathy in mucolipidosis type 2.
    Carboni E; Sestito S; Lucente M; Morrone A; Zampini L; Chimenz R; Ceravolo MD; De Sarro R; Ceravolo G; Calabrò MP; Parisi F; Moricca MT; Pensabene L; Musolino D; Concolino D
    J Biol Regul Homeost Agents; 2020; 34(4 Suppl. 2):71-77. SPECIAL ISSUE: FOCUS ON PEDIATRIC CARDIOLOGY. PubMed ID: 33000604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.